Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: October 16, 2019
The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency.
Journal: Endocrine connections
Published: September 18, 2017
A first-in-man phase 1 trial for long-acting TransCon Growth Hormone.
Journal: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
Published: August 18, 2017
A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency.
Journal: Endocrine connections
Published: February 10, 2017
A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 23, 2016
Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma.
Journal: BMJ open
Published: January 08, 2016
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.
Journal: The European respiratory journal
Published: January 08, 2015
Open-access biorepository for idiopathic pulmonary fibrosis. The way forward.
Journal: Annals of the American Thoracic Society
Published: August 29, 2014
All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.
Journal: American journal of respiratory and critical care medicine
Published: January 31, 2014
6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis.
Journal: The European respiratory journal
Published: December 07, 2013
Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis.
Journal: Respirology (Carlton, Vic.)
Published: November 18, 2013
Selection of clinically meaningful primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis.
Journal: American journal of respiratory and critical care medicine
Published: June 04, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026